Article Details
Retrieved on: 2023-01-08 12:32:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The talks fell through was due to Pfizer's high quotation for Paxlovid. Pfizer did not immeditately respond to a request to comment. (Reporting by ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here